Physician profile
Daniel Geller
NPI 1578618583
$958.12
in general payments reported to CMS, 2019-2025
14 companies · $92.70 in 2025
The $92.70 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $186 · 2021: $174 · 2022: $56.43 · 2023: $30.97 · 2024: $44.50 · 2025: $92.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $366.62 | 2019-2021 | |
| Bioventus LLC | $175.26 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Sandoz INC. | $64.65 | 2019 | |
| Depuy Synthes Sales INC. | $56.35 | 2025 | Hammerlock |
| Wright Medical Technology, INC. | $54.77 | 2019 | |
| Smith+Nephew, INC. | $51.69 | 2021-2023 | Stravix |
| Fusion Orthopedics USA, LLC | $36.35 | 2025 | |
| Zimmer Biomet Holdings, INC. | $32.74 | 2019 | |
| Kci USA, INC. | $30.84 | 2022 | |
| Glenmark Therapeutics INC. | $24.00 | 2019 | |
| Medtronic, INC. | $20.48 | 2024 | Accurian |
| Abbott Laboratories | $16.87 | 2023 | Eterna |
| Organogenesis INC. | $16.43 | 2020 | |
| Horizon Therapeutics Plc | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.